Duodenal mucosal ablation with irreversible electroporation reduces liver lipids in rats with non-alcoholic fatty liver disease

Figure 6 Enteroendocrine test and representative images of duodenal immunofluorescence staining. A: Serum gastric inhibitory polypeptide levels; B: Glucagon-like peptide-1; C: Cholecystokinin; D-I: Immunofluorescence staining of the duodenum from sham-control and duodenal mucosal ablation groups; J-L: Number of gastric inhibitory polypeptide⁺ cells, glucagon-like peptide-1⁺, and cholecystokinin⁺ cells among different groups. ^aP < 0.05 vs sham-control group, ^bP < 0.01 vs sham-control group. DMA: Duodenal mucosal ablation; GIP: Gastric inhibitory polypeptide; GLP-1: Glucagon-like peptide-1; CCK: Cholecystokinin.